| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Septerna, Inc.'s insiders have reduced their positions by a net 13,584 shares worth roughly $470K. In the past 30 days, 0 insiders bought and 2 sold. Sales set the recent tone.
On the other side, 2 insiders reduced their position over the period. SEPN sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 98.7K | $3.83M | -3,334 | |
| COO | 80.9K | $3.14M | -4,000 | |
| Dir | 33.2K | $1.29M | - | |
| VP | 15.4K | $597.5K | - | |
| 10% | 15.0K | $582.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Long Daniel D. | SVP, Drug Discovery | Sale+OE | 3,334 | $34.47 | $114,919.89 | -1.7% | - | - | |
| Jul 15, 2026 | Bhatt Elizabeth | President And COO | Sale+OE | 4,000 | $33.99 | $135,974.00 | -2.2% | - | - | |
| Jun 12, 2026 | Shaikhly Samira | Chief People Officer | Sale+OE | 6,250 | $35.08 | $219,224.37 | -88.7% | - | - | |
| Apr 15, 2026 | Bhatt Elizabeth | President And COO | Sale+OE | 4,000 | $24.34 | $97,343.36 | -0.8% | +33.2% | - | |
| Nov 10, 2025 | Long Daniel D. | SVP, Drug Discovery | Sell | 3,501 | $18.06 | $63,223.16 | -3.6% | +46.9% | - | |
| Mar 7, 2025 | Ezekowitz Alan86 | Director | Buy | 13,319 | $6.93 | $92,270.04 | +12.8% | +63.6% | +347.9% | |
| Mar 6, 2025 | Ezekowitz Alan86 | Director | Buy | 86,681 | $5.95 | $515,934.11 | +82.5% | +56.8% | +352.8% | |
| Feb 27, 2025 | Finer Jeffrey85 | CEO And President | Buy | 17,000 | $5.70 | $96,960.60 | +0.7% | +67.6% | +401.2% | |
| Feb 27, 2025 | Labrucherie Gil M84 | Chief Financial Officer | Buy | 10,000 | $5.69 | $56,866.68 | +15.1% | +67.6% | +401.2% | |
| Feb 24, 2025 | Third Rock Ventures Vi, L.P.84 | 10% Owner | Buy | 18,861 | $6.00 | $113,147.14 | +0.4% | +68.4% | +439.3% |